OP
Ono Pharmaceutical Co., Ltd.
OPHLF · OTC
$15.00 +0.00% (+$0.00)
1M -4.28%
Market Cap ¥1.08T
P/E Ratio 14.14x
Div. Yield 3.48%
ROE 9.07%
Bulios Fair Price
$16.14
7.6% upside
Current Price
$15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OPHLF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
95 /100
Cheap P/B 1.26x
P/S 2.14x
P/E 14.14x
Growth
24 /100
Declining Book val. growth 4.89%
FCF growth 3.20%
EPS growth 13.65%
Profitability
94 /100
Strong FCF margin 25.64%
Op. margin 22.05%
Gross margin 73.55%
Quality
47 /100
Average Asset turnover 0.47x
ROA 7.11%
ROIC 8.54%
Debt
100 /100
Low Net debt/EBITDA -0.68x
Int. coverage 31.46x
Debt/Equity 0.14x
Stability
56 /100
Moderate Profitable years 6
EPS volatility 52.03%
Beta 0.14x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OPHLF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Gyo Sagara
Employees
4,206
Headquarters
Osaka
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
29 OCT
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date